210 related articles for article (PubMed ID: 32663267)
1. Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review.
Papadakis I; Spanou A; Kalyvas D
J Oral Implantol; 2021 Apr; 47(2):169-180. PubMed ID: 32663267
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
Otto S; Schnoedt EM; Troeltzsch M; Kaeppler G; Aljohani S; Liebermann A; Fliefel R
J Oral Implantol; 2023 Feb; 49(1):39-45. PubMed ID: 35446931
[TBL] [Abstract][Full Text] [Related]
3. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
4. Is it safe to place implants in patients at risk of MRONJ?
Owen B; Bradley H
Evid Based Dent; 2021 Jan; 22(3):108-109. PubMed ID: 34561663
[TBL] [Abstract][Full Text] [Related]
5. Oral implant survival in patients with bisphosphonate (BP)/antiresorptive and radiation therapy and their impact on osteonecrosis of the jaws. A systematic review.
Schmitt CM; Buchbender M; Lutz R; Neukam FW
Eur J Oral Implantol; 2018; 11 Suppl 1():S93-S111. PubMed ID: 30109302
[TBL] [Abstract][Full Text] [Related]
6. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
7. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses.
Karna H; Gonzalez J; Radia HS; Sedghizadeh PP; Enciso R
Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314
[TBL] [Abstract][Full Text] [Related]
8. The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis.
Stavropoulos A; Bertl K; Pietschmann P; Pandis N; Schiødt M; Klinge B
Clin Oral Implants Res; 2018 Oct; 29 Suppl 18():54-92. PubMed ID: 30306695
[TBL] [Abstract][Full Text] [Related]
9. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
10. Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review.
Al-Omari FA; Kuroshima S; Sawase T
J Dent; 2023 Nov; 138():104682. PubMed ID: 37708930
[TBL] [Abstract][Full Text] [Related]
11. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
12. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.
Yamamoto S; Maeda K; Kouchi I; Hirai Y; Taniike N; Yamashita D; Imai Y; Takenobu T
J Oral Implantol; 2018 Oct; 44(5):359-364. PubMed ID: 29870295
[TBL] [Abstract][Full Text] [Related]
13. Medication-Related Osteonecrosis of the Jaw and Dental Implants Failures: A Systematic Review.
Guazzo R; Sbricoli L; Ricci S; Bressan E; Piattelli A; Iaculli F
J Oral Implantol; 2017 Feb; 43(1):51-57. PubMed ID: 28231038
[TBL] [Abstract][Full Text] [Related]
14. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
Neal TW; Schlieve T
J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181
[TBL] [Abstract][Full Text] [Related]
15. Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology.
Massaad J; Magremanne M
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e743-e748. PubMed ID: 34922047
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?
Troeltzsch M; Cagna D; Stähler P; Probst F; Kaeppler G; Troeltzsch M; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2016 Dec; 44(12):1945-1951. PubMed ID: 27836551
[TBL] [Abstract][Full Text] [Related]
17. Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy.
Laimer J; Hechenberger M; Müller D; Walch B; Kolk A; Schnabl D; Schomaker M; Bruckmoser E
Future Oncol; 2021 Jul; 17(21):2705-2711. PubMed ID: 33880956
[No Abstract] [Full Text] [Related]
18. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
Madrid C; Sanz M
Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
[TBL] [Abstract][Full Text] [Related]
19. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw and successful implant treatment in a patient on high-dose antiresorptive medication: A case report.
Ottesen C; Andersen SWM; Jensen SS; Kofod T; Gotfredsen K
Clin Exp Dent Res; 2022 Oct; 8(5):1059-1067. PubMed ID: 35894761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
